Abbvie (ABBV) Removed from BofA/Merrill Lynch US 1 List; PT Cut
Tweet
Share
E-mailGet Alerts ABBV Hot Sheet
Price: $169.54 --0%
Rating Summary:
20 Buy, 12 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 8 | New: 7
Rating Summary:
20 Buy, 12 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 8 | New: 7
Join SI Premium – FREE
BofA/Merrill Lynch lowered its price target on Buy-rated Abbvie (NYSE: ABBV) to $61.00 (from $65.00) on expectation that shareholders will vote against the Shire deal. In addition the stock was removed from the US 1 List.
For an analyst ratings summary and ratings history on Abbvie click here. For more ratings news on Abbvie click here.
Shares of Abbvie closed at $52.90 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ameriprise Financial (AMP) PT Raised to $480 at BofA Securities
- Fiserv (FI) PT Raised to $186 at Baird
- BofA Securities Upgrades Tesla (TSLA) to Buy on wind up of positive catalysts
Create E-mail Alert Related Categories
Analyst Comments, Analyst PT ChangeRelated Entities
US 1 ListSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
